Related Experiment Video
Updated: Aug 15, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Interactions of melatonin with various signaling pathways: implications for cancer therapy
Ainaz Mihanfar1, Bahman Yousefi2, Bita Azizzadeh3
1Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
Abstract:
Melatonin is a neuro-hormone with conserved roles in evolution. Initially synthetized as an antioxidant molecule, it has gained prominence as a key molecule in the regulation of the circadian rhythm. Melatonin exerts its effect by binding to cytoplasmic and intra-nuclear receptors, and is able to regulate the expression of key mediators of different signaling pathways. This ability has led scholars to investigate the role of melatonin in reversing the process of carcinogenesis, a process in which many signaling pathways are involved, and regulating these pathways may be of clinical significance. In this review, the role of melatonin in regulating multiple signaling pathways with important roles in cancer progression is discussed, and evidence regarding the beneficence of targeting malignancies with this approach is presented.
Insights
Melatonin, a neuro-hormone regulating circadian rhythms, shows potential in cancer treatment. This review explores how melatonin impacts cancer signaling pathways for therapeutic benefit.
Area of Science:
- Neuroendocrinology
- Oncology
- Molecular Biology
Background:
- Melatonin is an evolutionarily conserved neuro-hormone.
- Initially recognized for antioxidant and circadian rhythm regulation, it interacts with cellular receptors.
- Melatonin influences key signaling pathways involved in cellular processes.
Purpose of the Study:
- To review the role of melatonin in regulating signaling pathways crucial for cancer progression.
- To present evidence on the potential of targeting malignancies with melatonin.
Main Methods:
- Literature review of studies on melatonin and cancer signaling.
- Analysis of melatonin's interaction with cytoplasmic and intra-nuclear receptors.
- Examination of melatonin's regulatory effects on key mediators in cancer pathways.
Main Results:
- Melatonin regulates multiple signaling pathways implicated in cancer.
- Evidence suggests melatonin's beneficence in targeting various malignancies.
- Melatonin's ability to modulate signaling pathways offers clinical significance in oncology.
Conclusions:
- Melatonin demonstrates a significant role in modulating cancer progression through various signaling pathways.
- Targeting these pathways with melatonin presents a promising therapeutic strategy for malignancies.
- Further research into melatonin's oncostatic potential is warranted.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Management of Insomnia
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Mitogens and the Cell Cycle
Circadian Rhythms and Gene Regulation

